Skip to Main Content

Paper Details

A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma.
J Gastrointest Oncol
18
2022
Author NameAffiliation
Stephen Welch
Gun Ho JangOntario Institute for Cancer Research
Steven GallingerOntario Institute for Cancer Research
David W HedleyPrincess Margaret Cancer Centre, University Health Network
David W HedleyPrincess Margaret Cancer Centre, University Health Network, University of Toronto
Lillian L SiuPrincess Margaret Cancer Centre, University Health Network
Lillian L SiuPrincess Margaret Cancer Centre, University Health Network, University of Toronto
Philippe L BedardPrincess Margaret Cancer Centre, University Health Network
Philippe L BedardPrincess Margaret Cancer Centre, University Health Network, University of Toronto
  • 1 - 9

Datasets

Release 1.2